Assessment of the glucagon receptor blocker remd-477 on insulin requirements in type 1 diabetes
Ended Project Grant Awarded Last action
- Award ID
- R42DK108305
- Recipient
-
Remd Biotherapeutics Inc. UEI DXA8DRFBBBM5
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $1,653,666
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- Camarillo, CA, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $680,901 | |
| Amendment | $748,101 | |
| Amendment | $0 | |
| Original award | $224,664 |
Quick answers
Who received award R42DK108305?
R42DK108305 was awarded to Remd Biotherapeutics Inc. by National Institutes of Health (Department of Health and Human Services) on September 1, 2016.
How much is award R42DK108305 worth?
$1,653,666 has been obligated on R42DK108305.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award